Pensions & Investments Logo
ETF Exchange > ARCX:FBT ETF

ARCX:FBT - ETF Fact Sheet

First Trust NYSE Arca Biotechnology Index Fund ETF - USD

Fund Identification

Ticker

ARCX:FBT

ISIN

US33733E2037

Main Metrics

Price

$249.19

Expense Ratio

0.54%

AuM

$3,251.95M

Tracking Difference

-0.85%

Ratings

Trackinsight rating

Official Investment Strategy

The First Trust NYSE Arca Biotechnology Index Fund is an exchange-traded index fund. The investment objective of the Fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology IndexSM. The NYSE Arca Biotechnology IndexSM is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.

ARCX:FBT's historical prices, performance, and flows

024681012%
1m returns
9.47%
1m flows
$374M
* Net total returns
All data as of 16 July 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all ARCX:FBT data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

ARCX:FBT's characteristics

Manager statistics

415 funds, $288.88Bn in AUM

Benchmark

NYSE Arca Biotechnology Total Return Index - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing
ARCX:FBT's exposure

Countries

USA
84.60%
Other
15.40%

Sectors

Healthcare
100.00%

Top 5 holdings

Corcept Therapeutics, Inc.
5.10%
Bruker Corp.
4.71%
Veracyte, Inc.
4.70%
Illumina, Inc.
4.12%
NeoGenomics, Inc.
4.12%
Total holdings
30
Total weight of top 5
22.75%
12%